2FIRSTS Analysis of China's E-cigarette Exports to Japan in February, 2024

Industry Insight by 2FIRSTS
Apr.08.2024
2FIRSTS Analysis of China's E-cigarette Exports to Japan in February, 2024
China's e-cigarette exports to Japan in February 2024 saw a significant decline in both value and quantity.

According to the latest trade data released by the General Administration of Customs of the People's Republic of China, 2FIRSTS has compiled the e-cigarette export data to Japan for February 2024 as follows:

 

2月中国出口日本电子烟约2321.8万美元 环比下降15.65%
Image source: 2FIRSTS (created by Mincy)

 

The export volume was approximately $23.218 million, a decrease of 15.65% compared to the previous period and a decrease of 37.08% year-on-year.

 

2月中国出口日本电子烟约2321.8万美元 环比下降15.65%
Image source: 2FIRSTS (created by Mincy)

 

The export volume is approximately 131 tons, showing a month-on-month decrease of 20.87% and a year-on-year decrease of 47.21%.

 

2月中国出口日本电子烟约2321.8万美元 环比下降15.65%
Image source: 2FIRSTS (Chart by Mincy)

 

The export unit price is $176.55 per kilogram, which is an increase of 6.60% compared to the previous period and an increase of 19.19% year-on-year. The average price of "e-cigarettes and similar personal electronic vapor devices" is $39.36 per unit.

 

2月中国出口日本电子烟约2321.8万美元 环比下降15.65%
Image source: 2FIRSTS (created by Mincy)

 

e-cigarettes and similar personal electronic vapor devices" account for 100% of the export category, while "non-combustible products containing nicotine without tobacco or reconstituted tobacco" account for 0% of the total.

 

2FIRSTS Analysis of China's E-cigarette Exports to Japan in February, 2024
Image source: 2FIRSTS (Created by Mincy)

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

InterTabac 2025 Photo Gallery|Nicotine Pouch Exhibitors Surge: Booth Snapshot
InterTabac 2025 Photo Gallery|Nicotine Pouch Exhibitors Surge: Booth Snapshot
InterTabac 2025 in Dortmund has officially opened. At this year’s fair, numerous nicotine pouch brands are exhibiting, with their numbers rising significantly compared with last year.
Sep.19 by 2FIRSTS.ai
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore will classify the anesthetic etomidate as a Class C drug from September 1, with traffickers and users facing prosecution and a minimum one-year jail term. The move comes amid growing concerns over the health risks posed by etomidate-laced e-cigarettes, which have become increasingly popular. The government has stepped up enforcement efforts, seizing over 850 e-cigarettes in recent operations.
Aug.25 by 2FIRSTS.ai
Five arrested in Tarlac, Philippines after seizure of illegal e-cigarette products
Five arrested in Tarlac, Philippines after seizure of illegal e-cigarette products
The Philippines conducted a large-scale seizure of unregistered e-cigarettes, and five people were arrested and charged with illegally selling substandard products.
Sep.17 by 2FIRSTS.ai
Two South African students had their scholarships revoked for vaping; court rules the school's punishment invalid
Two South African students had their scholarships revoked for vaping; court rules the school's punishment invalid
Two South African students win court ruling against school's excessive e-cigarette punishment, violating "no double jeopardy" principle.
Sep.15 by 2FIRSTS.ai
First week of the ban: Wisconsin retail sales plunge 90%, inventories sealed, shelves left bare
First week of the ban: Wisconsin retail sales plunge 90%, inventories sealed, shelves left bare
After Wisconsin’s new vape ban took effect, many vape shops across the state reported emptied displays and sharp sales declines. The law requires the state Department of Revenue to fine retailers that sell vaping devices without U.S. Food and Drug Administration (FDA) authorization. The industry group WiscoFAST has sued the Wisconsin Department of Revenue, arguing the law improperly encroaches on federal oversight. Some business owners say sales have dropped by as much as 90% since the ban took
Sep.04 by 2FIRSTS.ai
Imperial Responds to 2Firsts: Disappointed by FDA Denial of blu Product
Imperial Responds to 2Firsts: Disappointed by FDA Denial of blu Product
2Firsts interviewed Imperial Brands on FDA’s blu denial. ITG Brands responded with disappointment, vowing to pursue a fair, science-based review.
Aug.22